The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Diverse Biochemical Properties of Shp2 Mutants
Open accessAbstract
Mutations in the Src homology 2 (SH2)-containing protein-tyrosine phosphatase Shp2 (PTPN11) underlie half of the cases of the autosomal dominant genetic disorder Noonan syndrome, and somatic Shp2 mutations are found in several hematologic and solid malignancies. Earlier studies of small numbers of mutants suggested that disease-associated mutations cause constitutive (SH2 binding-independent) activation and that cancer-associated mutants are more active than those associated with Noonan syndrome. We have characterized a larger panel of Shp2 mutants and find that this "activity-centric" model cannot explain the behaviors of all pathogenic Shp2 mutations. Instead, enzymatic, structural, and mathematical modeling analyses show that these mutants can affect basal activation, SH2 domain-phosphopeptide affinity, and/or substrate specificity to varying degrees. Furthermore, there is no absolute correlation between the mutants' extents of basal activation and the diseases they induce. We propose that activated mutants of Shp2 modulate signaling from specific stimuli to a subset of effectors and provide a theoretical framework for understanding the complex relationship between Shp2 activation, intracellular signaling, and pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nicholls, A., Sharp, K. A., & Honig, B. (1991) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340110407 · Cited by 5,240
Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome
Tartaglia, M., Mehler, E. L., Goldberg, R., Zampino, G., Brunner, H. G., Kremer, H., van der Burgt, I., Crosby, A. H., Ion, A., Jeffery, S., et al. (2001) · Nature Genetics · doi:10.1038/ng772 · Cited by 1,733
The ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
Neel, B. G., Gu, H., & Pao, L. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00091-4 · Cited by 1,249
Self-citationTartaglia, M., Niemeyer, C. M., Fragale, A., Song, X., Buechner, J., Jung, A., Hählen, K., Hasle, H., Licht, J. D., & Gelb, B. D. (2003) · Nature Genetics · doi:10.1038/ng1156 · Cited by 1,033
Crystal Structure of the Tyrosine Phosphatase SHP-2
Hof, P., Pluskey, S., Dhe-Paganon, S., Eck, M. J., & Shoelson, S. E. (1998) · Cell · doi:10.1016/s0092-8674(00)80938-1 · Cited by 985
IRS proteins and the common path to diabetes
White, M. F. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00514.2001 · Cited by 925
Catalytic specificity of protein-tyrosine kinases is critical for selective signalling
Songyang, Z., Carraway, K. L., Eck, M. J., Harrison, S. C., Feldman, R. A., Mohammadi, M., Schlessinger, J., Hubbard, S. R., Smith, D. P., Eng, C., et al. (1995) · Nature · doi:10.1038/373536a0 · Cited by 919
Self-citationTartaglia, M., Kalidas, K., Shaw, A., Song, X., Musat, D. L., van der Burgt, I., Brunner, H. G., Bertola, D. R., Crosby, A., Ion, A., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/340847 · Cited by 802
BRCT Repeats As Phosphopeptide-Binding Modules Involved in Protein Targeting
Manke, I. A., Lowery, D. M., Nguyen, A., & Yaffe, M. B. (2003) · Science · doi:10.1126/science.1088877 · Cited by 651
Bentires-Alj, M., Paez, J. G., David, F. S., Keilhack, H., Halmos, B., Naoki, K., Maris, J. M., Richardson, A., Bardelli, A., Sugarbaker, D. J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1923 · Cited by 509
Self-citationSalmeen, A., Andersen, J. N., Myers, M. P., Tonks, N. K., & Barford, D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00137-4 · Cited by 467
Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase
Zheng, X. M., Wang, Y., & Fallen, C. J. (1992) · Nature · doi:10.1038/359336a0 · Cited by 449
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis
Loh, M. L. (2004) · Blood · doi:10.1182/blood-2003-09-3287 · Cited by 427
The ‘Gab’ in signal transduction
Gu, H., & Neel, B. G. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00002-3 · Cited by 388
Self-citationLechleider, R. J., Sugimoto, S., Bennett, A. M., Kashishian, A. S., Cooper, J. A., Shoelson, S. E., Walsh, C. T., & Neel, B. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80562-6 · Cited by 319
Self-citationAcquiring signalling specificity from the cytokine receptor gp130
Ernst, M. (2004) · Trends in Genetics · doi:10.1016/j.tig.2003.11.003 · Cited by 299
Isolation of a src homology 2-containing tyrosine phosphatase.
Plutzky, J., Neel, B. G., & Rosenberg, R. D. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.3.1123 · Cited by 296
Self-citationPotent Stimulation of SH-PTP2 Phosphatase Activity by Simultaneous Occupancy of Both SH2 Domains
Pluskey, S., Wandless, T. J., Walsh, C. T., & Shoelson, S. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.2897 · Cited by 282
Mohi, M. G., Williams, I. R., Dearolf, C. R., Chan, G., Kutok, J. L., Cohen, S., Morgan, K., Boulton, C., Shigematsu, H., Keilhack, H., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.010 · Cited by 277
Self-citationSu, J., Muranjan, M., & Sap, J. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80234-6 · Cited by 267
Marino, B., Digilio, M. C., Toscano, A., Giannotti, A., & Dallapiccola, B. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70088-0 · Cited by 258
Pannifer, A. D. B., Flint, A. J., Tonks, N. K., & Barford, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10454 · Cited by 237
Araki, T., Nawa, H., & Neel, B. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306461200 · Cited by 231
Self-citationSugimoto, S., Wandless, T. J., Shoelson, S. E., Neel, B. G., & Walsh, C. T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36874-6 · Cited by 213
Self-citationA widely expressed human protein-tyrosine phosphatase containing src homology 2 domains.
Ahmad, S., Banville, D., Zhao, Z., Fischer, E. H., & Shen, S. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2197 · Cited by 212
Kazlauskas, A., Feng, G. S., Pawson, T., & Valius, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.6939 · Cited by 207
Lee, C.-H., Kominos, D., Jacques, S., Margolis, B., Schlessinger, J., Shoelson, S. E., & Kuriyan, J. (1994) · Structure · doi:10.1016/s0969-2126(00)00044-7 · Cited by 205
Ponniah, S., Wang, D. Z. M., Lim, K. L., & Pallen, C. J. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80238-3 · Cited by 203
Sarkozy, A., Conti, E., Seripa, D., Digilio, M. C., Grifone, N., Tandoi, C., Fazio, V. M., Di Ciommo, V, Marino, B., Pizzuti, A., et al. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.9.704 · Cited by 203
Eck, M. J., Pluskey, S., Trüb, T., Harrison, S. C., & Shoelson, S. E. (1996) · Nature · doi:10.1038/379277a0 · Cited by 199
Fragale, A., Tartaglia, M., Wu, J., & Gelb, B. D. (2004) · Human Mutation · doi:10.1002/humu.20005 · Cited by 194
Musante, L., Kehl, H. G., Majewski, F., Meinecke, P., Schweiger, S., Gillessen-Kaesbach, G., Wieczorek, D., Hinkel, G. K., Tinschert, S., Hoeltzenbein, M., et al. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200935 · Cited by 163
Piao, X., Paulson, R., van der Geer, P., Pawson, T., & Bernstein, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14665 · Cited by 160
Keilhack, H., Tenev, T., Nyakatura, E., Godovac-Zimmermann, J., Nielsen, L., Seedorf, K., & Böhmer, F.-D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.38.24839 · Cited by 160
Self-citationFunctional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells
Schubbert, S., Lieuw, K. H., Rowe, S. L., Lee, C. M., Li, X., Loh, M. L., Clapp, D. W., & Shannon, K. (2005) · Blood · doi:10.1182/blood-2004-11-4207 · Cited by 149
Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia
Niihori, T., Aoki, Y., Ohashi, H., Kurosawa, K., Kondoh, T., Ishikiriyama, S., Kawame, H., Kamasaki, H., Yamanaka, T., Takada, F., et al. (2005) · Journal of Human Genetics · doi:10.1007/s10038-005-0239-7 · Cited by 136
Kosaki, K., Suzuki, T. A., Muroya, K., Hasegawa, T., Sato, S., Matsuo, N., Kosaki, R., Nagai, T., Hasegawa, Y., & Ogata, T. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8694 · Cited by 125
Loh, M. L., Reynolds, M. G., Vattikuti, S., Gerbing, R. B., Alonzo, T. A., Carlson, E. J., Cheng, J. W., Lee, C. M., Lange, B. J., & Meshinchi, S. (2004) · Leukemia · doi:10.1038/sj.leu.2403492 · Cited by 121
Activated Mutants of SHP-2 Preferentially Induce Elongation of Xenopus Animal Caps
O’Reilly, A. M., Pluskey, S., Shoelson, S. E., & Neel, B. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.299-311.2000 · Cited by 118
Self-citationSHP-2 and myeloid malignancies
Tartaglia, M., Niemeyer, C. M., Shannon, K., & Loh, M. L. (2003) · Current Opinion in Hematology · doi:10.1097/00062752-200401000-00007 · Cited by 118
Yoshida, R. Y., Hasegawa, T., Hasegawa, Y., Nagai, T., Kinoshita, E., Tanaka, Y., Kanegane, H., Ohyama, K., Onishi, T., Hanew, K., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032091 · Cited by 111
Cheng, A., Bal, G. S., Kennedy, B. P., & Tremblay, M. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009734200 · Cited by 101
PTPN11 Mutations in Noonan syndrome type I: detection of recurrent mutations in exons 3 and 13
Maheshwari, M., Belmont, J. W., Fernbach, S. D., Ho, T., Molinari, L., Yakub, I., Yu, F., Combes, A., Towbin, J. A., Craigen, W. J., et al. (2002) · Human Mutation · doi:10.1002/humu.10129 · Cited by 89
Sugimoto, S., Lechleider, R. J., Shoelson, S. E., Neel, B. G., & Walsh, C. T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41593-1 · Cited by 86
Self-citationShimada, H., Mori, T., Shimasaki, N., Shimizu, K., Takahashi, T., & Kosaki, K. (2004) · Leukemia · doi:10.1038/sj.leu.2403374 · Cited by 9
Cited by
Protein tyrosine phosphatases: from genes, to function, to disease
Tonks, N. K. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2039 · Cited by 1,677
Hyperactive Ras in developmental disorders and cancer
Schubbert, S., Shannon, K., & Bollag, G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2109 · Cited by 1,583
Ras oncogenes: split personalities
Karnoub, A. E., & Weinberg, R. A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2438 · Cited by 1,467
A compendium of mutational cancer driver genes
Martínez-Jiménez, F., Muiños, F., Sentís, I., Deu-Pons, J., Reyes-Salazar, I., Arnedo-Pac, C., Mularoni, L., Pich, O., Bonet, J., Kranas, H., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0290-x · Cited by 1,296
Mechanisms of leptin action and leptin resistance.
Myers, M. G., Cowley, M. A., & Münzberg, H. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100707 · Cited by 1,074
Metadata
- Authors
- Keilhack, H., David, F. S., McGregor, M., Cantley, L. C., & Neel, B. G.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 280
- Issue
- 35
- Pages
- 30984-30993
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2043160859
- Cited by
- 298
- References
- 46
- FWCI
- 7.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.